These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22152382)

  • 41. [A multicenter study of the effectiveness of interferon alpha-1b (Hapgen) in treating HBeAg positive chronic hepatitis B patients].
    Jin R; Guo XH; Huang JF; Liu Z; Li HW; Wang ZB; Zhang B; Xie YM
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):25-8. PubMed ID: 21272454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Negative correlation between viral load and HBsAg levels in chronic HBV-infected patients.
    Ozdil B; Cosar AM; Akkiz H; Sandikci MU; Kece C
    Arch Virol; 2009; 154(9):1451-5. PubMed ID: 19672557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study.
    Gupta E; Kumar A; Choudhary A; Kumar M; Sarin SK
    Indian J Med Microbiol; 2012; 30(2):150-4. PubMed ID: 22664428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [S gene mutations in HBsAg/HBsAb double positive chronic hepatitis B patients].
    Zhang ZH; Peng J; Xia JB; Tian YJ; Jiang M; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):266-70. PubMed ID: 19403024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression and clinical significance of HBsAg and HBcAg in hepatocytes in chronic hepatitis B].
    Wang GS; Wang MM; Xie QL; Ming L; Jiang XN; Chen LW; Liu MH
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):287-9. PubMed ID: 15161505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
    Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
    Galli C; Orlandini E; Penzo L; Badiale R; Caltran G; Valverde S; Gessoni G
    J Med Virol; 2008 Jun; 80(6):974-9. PubMed ID: 18428144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B.
    Togo S; Arai M; Tawada A; Chiba T; Kanda T; Fujiwara K; Imazeki F; Yokosuka O
    J Viral Hepat; 2011 Oct; 18(10):e508-15. PubMed ID: 21914070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.
    Tseng TC; Liu CJ; Su TH; Wang CC; Chen CL; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2011 Aug; 141(2):517-25, 525.e1-2. PubMed ID: 21672542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
    Xie Y; Zhao H; Dai WS; Xu DZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dynamic study on the anti-HBs level of immunized children born to HBsAg-positive and HBsAg-negative mothers in hyperendemic area of hepatitis B].
    Gong J; Li RC; Li YP; Yang JY; Chen XR; Nong Y; Huang ZN; Li Q; Liu CB; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):13-6. PubMed ID: 18785470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
    Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance.
    Zhang ZH; Li L; Zhao XP; Glebe D; Bremer CM; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Gerlich W; Roggendorf M; Li X; Lu M; Yang DL
    J Viral Hepat; 2011 Jun; 18(6):424-33. PubMed ID: 20819150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J; Vodák M; Zichová M
    Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.